Your AI Doctor Is Coming | Julie Yoo
Julie Yoo, a healthcare investor at Andreessen Horowitz, argues that AI will benefit healthcare more than any other industry because healthcare has historically underinvested in technology, allowing it to leapfrog legacy systems and adopt AI-native solutions directly. She identifies major opportunities in consumer healthcare, AI-native care delivery, robotics, and new payment models, predicting a future where individuals have personalized AI doctors available continuously.
Summary
Julie Yoo shares her 18-year journey in healthcare technology, beginning as a software engineer before transitioning to healthcare during the electronic health records (EHR) digitization era. She founded Kairos, a company addressing the healthcare access paradox—where patients wait months for appointments despite physicians operating below full capacity. After selling Kairos, she joined Andreessen Horowitz as a healthcare investor.
Yoo identifies three major factors driving healthcare's current renaissance: First, consumer expectations have risen due to superior experiences in other industries (Uber, Airbnb, Instacart), creating a gap with stagnant healthcare services. Second, incumbent healthcare systems face mounting cost pressures from expensive labor, talent shortages following COVID, and government cost-containment efforts. Third, AI technology now provides abundant intelligence that can replace scarce medical expertise, making previously impossible solutions feasible.
A critical advantage healthcare holds is its historical underinvestment in technology infrastructure. Unlike other industries that spent decades building middleware software layers, healthcare relied primarily on EHRs and labor. This lower sunk cost bias allows healthcare to leapfrog directly to AI-native workflows rather than ripping out legacy systems. Yoo notes this is the first organic adoption wave in health tech, where physicians voluntarily use AI tools because they genuinely improve work.
On the consumer side, AI chatbots have normalized accessing health information with lower friction than traditional appointments. Companies like Council Health exemplify new possibilities—24/7 asynchronous chat with licensed MDs who can diagnose, prescribe, and refer, combining AI efficiency with clinical credibility. The shift from employer-paid insurance to consumer cost-sharing has made individuals price-sensitive, driving demand for disruptively cheaper AI-enabled services.
Yoo highlights major opportunity areas: consumer health businesses with viable cash-pay models, AI-native and AI-proof companies combining AI intelligence with regulated services, robotics in high-acuity settings, and ambitious companies reimagining healthcare payment systems entirely. She predicts that within a decade, healthcare will feature end-of-one personalized solutions driven by continuous self-generated data, and individuals will have AI doctors in their pockets providing continuous, personalized specialist-level care.
About this episode
a16z General Partner Julie Yoo joins MTS host Sophia Dew to explain why she believes healthcare could benefit more from AI than almost any other industry, and why decades of slow technology adoption may actually give healthcare an advantage in the AI era. Julie traces healthcare’s evolution from paper records and fax machines through electronic health records and telehealth, and explains why AI represents something different: an organic adoption wave driven by tools that doctors and patients actually want to use. Because healthcare never built the same layers of legacy software as other industries, it may now be able to leapfrog directly into agentic AI. They also explore how AI could dramatically lower the cost of care, why consumers are becoming a more important payer, where Julie sees the biggest opportunities for healthcare founders, and a future where everyone has a highly personalized AI doctor in their pocket for life.
Key Insights
- Healthcare's historical underinvestment in technology infrastructure is now an advantage, allowing the industry to adopt AI-native workflows directly without the costly rip-and-replace efforts other industries must undertake with their existing middleware layers.
- This is the first organic adoption wave in healthcare technology where physicians voluntarily adopt AI tools because they genuinely improve clinical work, contrasting sharply with previous unnatural adoption periods that required government incentives or crisis-driven mandates like COVID.
- The shift from employer-covered insurance to consumer cost-sharing through high deductibles fundamentally changed patient behavior, making individuals price-sensitive and enabling new $10-per-month AI-powered services that deliver dramatically better value than traditional healthcare.
- AI-native healthcare companies achieve sustainable competitive advantages by combining AI intelligence with regulated clinical services (diagnosis, prescription, referral), creating surface area and cost structures impossible through historical means while maintaining clinical credibility.
- Healthcare's sparse data problem—patients see traditional doctors only about once annually—means current datasets are insufficient to train truly comprehensive medical AI, creating opportunity for companies generating continuous end-of-one health data that will enable next-generation models.
Topics
Transcript
Healthcare is one of the most expensive industries in the world, yet time and medical expertise remain scarce. Julie Yu thinks AI could change that. The A16Z General Partner joins Sophia Du on MTS to explain why healthcare may benefit more from AI than almost any other industry, and why its slow adoption of technology could now be an advantage, allowing it to leapfrog legacy software and move directly to AI-native workflows. Julie also shares where she sees the biggest opportunities for founders, from consumer healthcare and AI-native care delivery, to robotics and new payment models, and why the future could include an AI doctor in your pocket for life. Julie, welcome to MTS. Thanks so much for having me.…
Full transcript available for MurmurCast members
Sign Up to AccessMore from The a16z Show
The Top 100 Consumer AI Apps: Who’s Actually Paying?
A16Z's seventh edition Top 100 Consumer AI Apps Report reveals that while half of Americans use AI, only 4.5% pay for subscriptions, with spending heavily concentrated among developers and power users. The report highlights emerging personal agents as a major trend, significant divergence between ChatGPT, Claude, and Gemini, and substantial untapped opportunities in categories like dating, social, shopping, and entertainment.
David George & Jack Altman on AI, Autonomy, and the Next $25 Trillion
David George from Andreessen Horowitz argues that AI, autonomy, and robotics will create over $25 trillion in market value over the next decade, with success across multiple layers of the stack—frontier models, open source, and applications will all flourish due to massive supply constraints and early-stage demand penetration among knowledge workers.
Beyond the God Model | Alex Atallah & Amjad Masad
Alex Atallah (OpenRouter) and Amjad Masad (Replit) discuss how the future of AI development lies in specialized, diverse models working together rather than relying on single AGI-like models. They argue that enterprises need independence from foundation model providers through model diversity, cost efficiency, and ownership of their own AI capabilities, while also addressing the risks of general-purpose agents and the importance of model specialization.
Why AI Agents Can Beat the Incumbents
Leo, an AI-native startup, is building multi-agent systems to automate end-to-end procurement processes for enterprises by coordinating work across multiple departments, stakeholders, and external systems that traditional procurement software cannot handle. The company differentiates itself from incumbents by owning the entire job workflow rather than being confined to a single system of record, and builds customer trust through human-in-the-loop approaches before scaling to fully autonomous negotiations.
The $1 Trillion AI Buildout | State of Markets
A16Z partners discuss the $1 trillion AI infrastructure buildout, arguing it's driven by real earnings growth rather than inflated valuations, with adoption still extremely early at the enterprise level. They highlight opportunities across consumer agents, robotics, autonomous vehicles, and enterprise diffusion, while noting that the market's 90% gain since ChatGPT reflects fundamental business performance rather than speculative excess.